Findings presented at the European Respiratory Society Congress 2026 suggest semaglutide may offer respiratory benefits beyond its approved diabetes and obesity indications.
|Articles|February 15, 2022
Daily OTC Pearl: FlorastorKids
Author(s)Saro Arakelians, PharmD
FlorastorKids is a daily probiotic supplement for children’s digestive and immune support.
Advertisement
OTC/Lifestyle Pearl of the Day: FlorastorKids
Indication: FlorastorKids is used for children’s digestive and immune support.
Insight:
- Active ingredients: Fructose 471.9 mg, saccharomyces boulardi CNCM I-745, 250 mg, lactose 32.5 mg.
- Directions: One sachet 1 to 2 times daily. Mix into food or beverage.
- Facts: Gluten-free, non-GMO, vegetarian, appropriate for lactose intolerance.
- Cautions: Do not refrigerate and keep out of the reach of children.
Sources:
Advertisement
Related to this article
Ataxia-telangiectasia (A-T) is a rare neurodegenerative disorder that primarily affects the nervous system, causing progressive loss of muscle control and coordination.
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
Most patients screened by a hospital pharmacist-led transitions-of-care service had unmet pneumococcal and other vaccine needs, and most accepted vaccination when offered.
The data helps pharmaicts predict who will react strongly to mRNA vaccines—giving them a science-backed talking point during respiratory season.
CDC-recommended adult vaccination programs for pneumococcal disease, RSV, influenza, and COVID-19 prevent over 182,000 deaths and generate up to $12 in societal value for every $1 spent.
Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
This article discusses a recent publication examining pharmacy access across Minnesota and explores the complex factors contributing to threatened community health access across the US.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
FDA Approves Levacetylleucine to Treat Ataxia in Adult, Pediatric Patients With A-T
3
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
4
Baseline Interferon Activity in Monocytes Predicts mRNA Vaccine Adverse Effects, Study Finds
5